Viewing Study NCT05999929



Ignite Creation Date: 2024-05-06 @ 7:23 PM
Last Modification Date: 2024-10-26 @ 3:06 PM
Study NCT ID: NCT05999929
Status: RECRUITING
Last Update Posted: 2023-08-21
First Post: 2023-08-03

Brief Title: Memory Support System Feasibility Study
Sponsor: Bruyere Research Institute
Organization: Bruyere Research Institute

Study Overview

Official Title: Implementation of the Memory Support System A Feasibility Study
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determining the feasibility of providing the Memory Support System MSS to individuals with mild cognitive impairment MCI and their partners at a clinic in Ontario Canada This will involve a collecting information from patients referred to the a memory clinic and geriatric day hospital about the patients interest in and the patients preferred method to administer the MSS and b a cost analysis related to implementation of the MSS The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs self-efficacy for memory quality of life mood anxiety and caregiver burden among a sample of individuals with MCI and their care partners
Detailed Description: A survey will be created and sent out to participants with MCI who have expressed interest in participating in research and have been seen at a memory clinic or geriatric day hospital after the initiation of the study The survey will consist of a Likert scale and open questions related to patient interest in and preferred length of MSS administration and preference for in-person versus virtual administration

During and after collection of the survey data a sample of 20 individuals with MCI ages 50 and their care partners will undergo MSS training

At enrollment in the MSS training participants with MCI and their care partners will complete measures of cognitive and functional status Participants and partners will also complete measures of treatment adherence IADLs self-efficacy for memory quality of life mood anxiety and caregiver burden at baseline treatment end and 8-week follow-up Participants will complete the MSS training consisting of ten 1-hour sessions delivered over two or six weeks starting 7-10 days after initial assessment Training will be offered in English or French After the intervention participants and their partners will complete a semi-structured interview seeking suggestions for improving the MSS teaching curriculum and intervention logistics

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None